Please wait
S-3 424B7 EX-FILING FEES 333-284878 0001601830 RECURSION PHARMACEUTICALS, INC. The prospectus is not a final prospectus for the related offering. 0001601830 2025-07-07 2025-07-07 0001601830 1 2025-07-07 2025-07-07 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

RECURSION PHARMACEUTICALS, INC.

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Class A Common Stock, par value $0.00001 per share 457(r) 1,457,952 $ 5.01 $ 7,304,339.52 0.0001531 $ 1,118.29
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 7,304,339.52

$ 1,118.29

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 1,118.29

Offering Note

1

In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), Recursion Pharmaceutics, Inc. (the "Registrant") initially deferred payment of all of the registration fees for the registration statement on Form S-3ASR (File No. 333- 284878), filed on February 12, 2025 (the "Registration Statement"). This "Calculation of Filing Fee Table" shall be deemed to update the "Calculation of Registration Fee" table in the Registration Statement. The prospectus to which this Exhibit is attached is a final prospectus supplement for the related offering. The maximum offering price per share was estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the Registrant's Class A Common Stock on the Nasdaq Global Select Market on July 7, 2025.